- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
In a new petition from Americans for Safe Access and Change.org, over 70,000 people and counting, are calling on the Drug Enforcement Administration to stop disseminating false information about medical cannabis immediately and ensure that any future information about medical cannabis treatment reflects medically-accurate and up-to-date facts.
The petition, which calls on President Obama to take immediate action, comes as the US Senate begins confirmation hearings for Senator Jeff Sessions’ (R-AL) appointment to Attorney General. Senator Sessions has actively opposed the use of medical and recreational cannabis saying, “good people don’t smoke marijuana” and argued that cannabis is a gateway drug that leads to cocaine and heroin use, something that has been resoundingly disproved by scientific evidence.
View the petition here: https://www.change.org/p/president-obama-make-the-dea-tell-the-truth-about-marijuana
Last month, Americans for Safe Access (ASA), a national nonprofit organization dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, filed a legal request with the Department of Justice demanding that the DEA immediately update misinformation about cannabis. The request asks specifically for the clearing of misconceptions that cannabis is a gateway drug and causes irreversible cognitive decline in adults, psychosis, and lung cancer. The filing references the Information Quality Act (IQA, aka Data Quality Act), which requires administrative agencies to devise guidelines that ensure the “quality, objectivity, utility, and integrity of information” they distribute and to “[e]stablish administrative mechanisms allowing affected persons to seek and obtain correction of information maintained and disseminated by the agency that does not comply with the guidelines.”
If granted, the filing could bring major changes to the way medical cannabis laws and regulations are treated by public officials. For decades, politicians have stated that now-disproven harmful effects were reasons to either prohibit or impose burdens on patients seeking safe and legal access to medical cannabis. While the DEA admitted in August that the gateway theory and other harmful claims are not supported by science, they have yet to remove all references of the disproven information, thereby continuing to spread inaccurate information.
“The DEA has actually admitted that cannabis is not a gateway drug and does not cause long-term brain damage, psychosis, and other alleged harms, yet they keep distributing this false information anyway, despite the reality these claims are not based on scientific fact," said Beth Collins, Senior Director of Government Relations and External Affairs for Americans for Safe Access. “It's illegal for the government to disseminate inaccurate information and the DEA must be held accountable. This misinformation hurts the millions of medical cannabis patients in the 29 states where cannabis treatment is legal, as well as patients in other states who are working to pass laws, for whom safe and reliable access to marijuana is a matter of necessity."